FDA.reportPublic FDA data

amLODIPine 2.5 MG Powder for Oral Solution

RxCUI
2726058
RxNorm name
amLODIPine 2.5 MG Powder for Oral Solution
Display name
amLODIPine 2.5 MG Powder for Oral Solution
Full name
amLODIPine 2.5 MG Powder for Oral Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:07

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
886a7f97-60a4-4206-a6c7-5206069ed487amLODIPine 2.5 MG Powder for Oral Solution [PSN] · amlodipine 2.5 MG Powder for Oral Solution [SCD] · amlodipine 2.5 MG (as amlodipine besylate 3.47 MG) Powder for Oral Solution [SY]34These highlights do not include all the information needed to use Sdamlo safely and effectively. See full prescribing information for Sdamlo. Sdamlo (amlodipine) for oral solution. Initial U.S. Approval: 199220251103